INNOVATIVE CANCER DIAGNOSTICS FOR HEALTHIER LIVES
one test at a time
At New Day Diagnostics, our mission is clear: to empower patients with affordable, accessible, and innovative diagnostic solutions that make a real difference in their lives. We are your dedicated ally in bringing groundbreaking diagnostic ideas to life, from coloretcal cancer blood tests to digestive disease testing and everything in between.
wE BRING YOUR VISIONS TO LIFE WITH
COMPREHENSIVE DIAGNOSTIC SOLUTIONS
Our high-complexity CLIA-certified laboratory ensures accurate and reliable Coloretcal Cancer testing, utilizing cutting-edge technology to deliver actionable insights for physicians.
Our CRO approach is unique and we pride ourselves in offering a personalized, white glove/a la carte level of service that focuses on cost effectiveness, speed, and agility for your studies.
PRODUCTS & PIPELINE
Our commercial diagnostic products in oncology, infectious disease, and digestive disease stem from a passion for innovation and a desire to transform patient care.
WHAT SETS Us APART
1. CLINICAL CANCER Laboratory excellence
Our commercial reference laboratory is certified to perform high-complexity testing. With the upcoming launch of our blood-based Colorectal Cancer (CRC) diagnostic test, we deliver accurate, timely, affordable test results – always with the patient in mind.
2. a multifaceted approach
Our robust pipeline of commercial diagnostic products spans across key areas including oncology, infectious disease, digestive disease, and will soon add women’s health ensuring we’re at the forefont of medical innovation.
3. full-service diagnostics consolidation
New Day Diagnostics is more than a company; we’re a full-service diagnostics consolidator. Our vertically integrated in-house ISO 13485 certified R&D, Clinical Research Organization (CRO) capabilities, CLIA-certified patient testing laboratory, and strategic commercialization partnerships mean we’ve got every step covered.
4. navigating complexity
With a proven track record in navigating complex regulatory landscapes, including FDA PMA, 510k, EUA, and EU CE-IVD, you can trust us to guide your diagnostic concept through the most challenging regulatory environments.
5. global distribution
Our strategic distribution partnerships across North America, Southeast Asia, Europe, the Middle East, and Africa ensure that your diagnostic innovations reach those who need them.